NIH Director, Dr. Francis Collins, blogs about Dr. Davis’ research on GluCEST imaging with Dr. Favinder Reddy. Dr. Collins writes: “If they are successful, this new tool could yield important insights into epilepsy and a variety of other neurological disorders in which glutamate is thought to play an important role, including schizophrenia, Alzheimer’s disease, Parkinson’s disease, and maybe even autism.”
Read full NIH Blog HERE.